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 Novel polymeric dispersions were prepared using the solvate form of 
griseofulvin 
 Enhanced antifungal properties were found for the dispersions 
prepared using HPMCAS 
 A correlation between the interactions in the solid and liquid was found 










Fungal biofilms are invariably recalcitrant to antifungal drugs and thus can 
cause recurrent serious infections. The aim of this work was to prepare highly 
effective form of the antifungal drug griseofulvin using the chloroform solvate 
embedded into different polymeric matrices. Based on their solid solubility, 
solvated (chloroform) and non-solvated (methanol and acetone) solid 
dispersions were prepared using different materials: silica, microcrystalline 
cellulose, polyvinylpyrrolidone and hydroxypropyl methylcellulose acetate 
succinate (HPMCAS) by which HPMCAS dispersions showed the highest 
solubility of about 200 μg/mL compared with ~30 μg/mL for pure griseofulvin.  
The anti fungal potential of griseofulvin was assessed against the 
dermatophytes T. rubrum.  Metabolic and protease activity of T. rubrum NCPF 
935 with and without the presence of GF:HPMCAS chloroform solvates 
showed significant reduction compared to the untreated control after 24 h 
period. Confocal laser scanning microscopy showed thin hyphae compared to 
Control and GF:HPMCAS (non solvated).  Dynamic vapour sorption data 
showed that HPMCAS formed most stable solvate structure preventing 
recrystallization and solvate expulsion, which could explain the disruptive 
effect of the biofilms. This could be explained by the formed hydrogen bonds 
as revealed by the solid and liquid state NMR data, which was further 
confirmed via thermal and FTIR analyses.  













1. Introduction  
  
Biofilms are surface-associated microbial communities that exist within a self-
secreted matrix consisting primarily of polysaccharides, proteins and nucleic 
acids forming the biofilm extracellular matrix (ECM) [1, 2]. Biofilm structures 
formed by fungi may present favourable conditions for survival within an 
infected host [3]. Dermatophytes such as T. rubrum,  keratinolytic, saprophytic 
fungi, are known to form biofilm and commonly implicated as a common 
cause for athlete’s foot and fungal infection of the nails [4]. Griseofulvin is one 
of the most commonly used antimicrobials to treat dermatophytosis caused by 
T. rubrum [5] nevertheless, there have been reports of increased incidence of 
resistance to griseofulvin, which makes treatment with griseofulvin less 
effective [6, 7]. This could be attributed to the biofilm formation and longer 
duration needed to complete the treatment.    
 
The low aqueous solubility of griseofulvin makes its formulation particularly 
challenging for oral drug delivery , which results in larger doses needed to 
reach a therapeutic level. Hence, the challenge in improving the antifungal 
activity of griseofulvin is two folds; first to improve its aqueous solubility and 
secondly to overcome resistance due to biofilm formation.  Crystal 
modifications of drug forming metastable drug polymorphs, hydrates, and co-
crystals have been among various approaches to improve aqueous solubility 










Solvates (also known as pseudopolymorphs) comprise of solvent-drug 
crystals, which have completely different structural configuration to the parent 
drug crystals [11].  Recently, it has been shown that ethanol solvates can 
significantly improve the dissolution of pioglitazone with potential 
enhancement of in vivo levels in beagle dogs [12].  It is generally agreed that 
solvates can form through either adsorption to the crystal cell surface or 
though occupying voids within imperfect crystals [13].  It was shown recently 
that dextran shell nanoparticles eradicated biofilms of various multidrug-
resistant Gram-positive bacteria [14].  This effect was attributed to improved 
solubility of the bacteria-nanoparticles complex due to the presence of the 
dextran shell [14].  Based on chloroform solvate, the aim of this work was to 
prepare a highly synergistic solvate form of griseofulvin able to diffuse across 
the biofilms and enhance their solubility.  The solvate form is stabilised within 
a polymeric matrix, which will also help to enhance the aqueous solubility of 
the embedded drug.   
 
Griseofulvin (GF) was embedded within different matrices, namely silica, 
microcrystalline cellulose (MCC), polyvinylpyrrolidone  (PVP) and 
hydroxypropyl methylcellulose acetate succinate (HPMCAS). GF and the 
polymer dispersions were prepared using acetone, methanol and chloroform 
as solvents. They were selected because of their distinct properties in terms 
of hydrogen bonds formation, boiling point and polarity.  Chloroform and 
methanol are Lewis acids with unique properties of chloroform to form Cl…Cl 
interactions while acetone is Lewis base with distinct proton accepting 









of drug excipient interactions on crystallization behaviour.  Silica is amorphous 
that lacks hydrogen bonding ability, PVP is a Lewis base amorphous polymer 
able to accept hydrogen bonds, MCC is partially crystalline able to accept and 
donate hydrogen bonds while HPMCAS is amorphous polymer and hydrogen 
bond acceptor and donor.  
 
 
2. Experimental Section 
2.1. Materials 
 
Griseofulvin 97%, silicon dioxide nanopowder 99.5%, microcrystalline 
cellulose (MCC) and polyvinylpyrrolidone (PVP) K30 were purchased from 
Sigma-Aldrich (Dorset, UK). Hydroxypropyl methylcellulose acetate succinate 
(HPMCAS) was obtained from Shin-Etsu Chemical Co. Ltd (Tokyo, Japan). 
Acetone, chloroform and methanol were purchased from Fisher Scientific 
(Loughborough, UK). Ethanol, potassium dihydrogen phosphate, KH2PO4 




2.2. Dynamic vapor sorption 
Solid dispersions of GF (10 mg) were weighed at 25 °C using a Dynamic 
Vapor Sorption analyzer (SMS, UK). Two sources of nitrogen gas were used 
where one of them is a dry gas while the second is 100% moist.  By mixing 









weight was recorded using a two-arm balance where the reference pan was 
empty and the sample pan was filled with the sample.  Nitrogen gas was 
passed over the sample to remove the residual solvent content (using 0% 
relative humidity).  Once this was achieved, nitrogen gas is passed with the 
desired relative humidity (RH).  
 
2.3. Differential Scanning Calorimetry (DSC)  
Thermal analysis was performed on a 2920 TA Instruments (Hertfordshire, 
UK) differential scanning calorimeter calibrated with indium using a purge of 
nitrogen gas at 20mL/min. A pinhole was created on an aluminium lid (TA 
instruments) to remove residual solvent. 8-10mg of sample was loaded into 
an aluminium pan and hermetically sealed. The samples were scanned from 
10ºC to 250ºC using a heating rate of 10ºC/min.  The melting enthalpy, onset 
and peak melting temperature were recorded and their values represent an 
average value of triplicates.  
 
 
2.4. Fourier transform infrared spectroscopy (FTIR) 
FTIR was performed on the prepared dispersions to examine potential 
hydrogen bonding between GF and the polymers. The infrared spectra of 
samples were obtained using Perkin Elmer Spectrum One FTIR spectrometer, 
equipped with a diamond attenuated total reflectance (ATR) accessory 
(Shelton, Connecticut, USA). A total of 64 scans were collected for each 










2.5. Saturation solubility measurements  
From each solid mixture quantities equivalent to 5mg-10mg equivalent of 
griseofulvin was weighed. 1mL of phosphate buffer was added into the 
microtube which was then loaded on a Stuart SB2 rotary mixer (Staffordshire, 
UK) and mixed for 1, 3, 5 and 72 h.  This was followed by centrifugation for 10 
min at 13000 RPM on a Heraeus Biofuge Pico 24-place microliter centrifuge 
(Thermo Scientific, Hertfordshire, UK). The supernatant was separated and 
the UV absorbances of the supernatants were measured using a Thermo 
Scientific Spectronic spectrophotometer (Thermo Scientific, Waltham, USA) 
using a wavelength of 295nm.  Absorbance values were converted into 
solubility values using standard calibration curve of griseofulvin.  Solubility 
studies were conducted in triplicates and the average and standard deviations 
were calculated.  
 
 
2.6. Temperature controlled X-ray powder diffraction  
The polymorphic nature of the formed samples was studies using x-ray 
powder diffraction (XRPD).  All samples were scanned using a Bruker D8 
advance X-ray diffractometer (Bruker AXS GmbH, Germany) which is a Cu-
source, theta– theta diffractometer equipped with a Lynx eye position 
sensitive detector. It was operated at 40 kV generator voltage and 40 mA 
generator current. The samples were analysed using DFFRAC plus XRD 
commander software (Bruker AXS GmbH, Germany) with a 2θ range of 5-45°, 









diffraction data were collected on Bruker D8 Advance Material lightly ground 
and packed in 0.7 mm capillary, which was then heated with a co-axially, 
mounted cryostream.  Compact controller set to ramp to temperature, then 
held for 5 minutes to allow the capillary to warm up, before collecting data. 
This was followed by a ramp to next temperature, hold, collect cycle within a 
temperature range of 30-200 °C. 
 
2.7. Solid and liquid state NMR  
Solid and liquid state NMR studies were used to investigate structural 
changes of GF within the solvated and non-solvated polymeric matrices.  1H 
and 13C NMR spectra of GF chloroform-d solution were recorded on Bruker 
Avance III spectrometer (Bruker, Germany) operating at Larmor frequency of 
500 MHz (11.75T) and 125.78 MHz, respectively. The 32 transient were 
recorded and average into each 1H spectrum. The proton decoupled 13C 
experiment required 1024 transients, and was recorded with 8 sec relaxation 
delay. The selected 2D experiments (e.g. COSY, TOCSY, HSQC and HMBC) 
were also recorded to confirm the assignments of the GF peaks to the 
molecular structure (data not shown). All spectra were referenced using TSP 
signal at 0 ppm. 
 
The 13C solid-state cross-polarization magic angle spinning (CPMAS) NMR 
spectra were recorded on Bruker Avance III spectrometer (Bruker, Germany) 
operating at Larmor frequency of 125.78 MHz (11.75T). The standard bore 
MAS probe was used in conjunction with 4 mm diameter zirconia rotors, which 









pulse width was 3.7 us at a power level of 32 W. Between 256 (for GF and 
HPMCAS) and 1024 (all other samples) signal transients were accumulated 
with 6 sec relaxation delays at ambient temperature.  All spectra were 
referenced to external adamantane signal as a secondary reference 
(frequency peak at 38.0 ppm). 
 
2.8. Preparation of drug-polymer solvates and non-solvated 
counterparts   
Fixed weight ratios (w/w ratios) of GF and polymer, i.e. silica, microcrystalline 
cellulose (MCC), polyvinylpyrrolidone  (PVP) and hydroxypropyl 
methylcellulose acetate succinate (HPMCAS) were weighed and fully 
dissolved in solvent of choice (acetone, methanol or chloroform) which was 
then removed using rotary evaporator (Buchi Rotavapor RE-111, Oldham, 
UK) with a set water bath temperature of 40 °C.  The solid remained in the 
flask was transferred to another container and placed under vacuum to be 
dried for 24h to eliminate any residual solvent. The resultant solid was co-
ground for 10min and sieved via 80 μm sieve.   
 
2.9. Preparation of fungal inoculum 
In order to study differences among prepared formulations, in vitro studies 
were carried out using fungal biofilms. T. rubrum NCPF 935 (PHE, UK) 
inoculum was prepared from initial growth on potato dextrose agar (PDA) 
(Sigma-Aldrich, UK) as mentioned by Brilhante et al., 2017 with a few 
modifications [15]. Briefly, 39 g/L of the solids were fully dissolved in 1 L of 









poured into petri plates once it had cooled down to ~ 55 oC and allowed to 
set. A small piece of T. rubrum NCFP 935 was excised from the stock and 
placed in the centre of the PDA plates and allowed to grow for a period of 7-
10 days at 28 oC for optimal sporulation. The conidia and hyphal fragments 
were harvested by covering the cultures with 5 mL of sterile 0.9% saline 
solution and by passing a sterile swab over the surface of the cultures. The 
0.9% saline solution containing the conidia and hyphal fragments was then 
collected and allowed to settle for 5 min at 28 oC to sediment the hyphae and 
separate the conidia. The conidium suspension was then gently aspirated and 
transferred to fresh sterile tubes and serially diluted to obtain a suspension 
containing ~ 5 x 106 cfu/ mL. This was based on cell count performed using a 
haemocytometer. The conidia suspension was then diluted with 0.9% saline 
solution to obtain a concentration of ~ 1 x106 cfu/ mL for biofilm formation and 
subsequent experiments.  
 
2.10 Working stock of griseofulvin formulations for biofilm assay 
 
GF:HPMCAS formulations were initially dissolved in DMSO (dimethyl 
sulfoxide) (Sigma-Aldrich, UK) according to the CLSI broth microdilution 
protocol (Wayne, 2008) to a concentration of 800 g/ mL. The formulations 
were then further diluted in RPMI 1640 medium, buffered to pH 7 with MOPS 
to obtain the desired concentrations for biofilm formation assay.  
 
2.11. T. rubrum NCPF 935 biofilm formation assay 
Biofilm formation by T. rubrum NCPF 935 was performed based on the 









al., 2014 with a few modifications [16]. Briefly, 250 L of the pre-adjusted (~1 
x 106 cfu/ mL) conidia suspension was added to 96-well plates as required. 
The plates were then incubated at 37 oC for 3 h for adhesion of the conidia to 
the surface of the wells under static conditions. Subsequently, the growth 
suspension was replaced with pre-sterilised 250 L of RPMI 1640 (pH 7) 
medium containing GF:HPMCAS (chloroform solvate) and non solvated 
(prepared from acetone). The concentration of the formulations used in this 
study were equivalent to the MIC of griseofulvin against T. rubrum (8 g/ mL), 
which were prepared following CLSI (the clinical and laboratory standards 
institute guidelines) M38-A2 for fungal work. Biofilm of T. rubrum NCPF 935 
was grown with and without the addition of the formulation and grown for a 
period of 96 h at 37 oC prior to carrying out subsequent assays.  
 
 
2.12. Quantification of T. rubrum NCPF biofilm by safranin staining 
Biofilm formation by T. rubrum NCPF 935 was performed based on previous 
method with a few modifications [16, 17]. Briefly, 250 L of the pre-adjusted 
(~1 x 106 cfu/ mL) conidia suspension was added to 96-well plates as 
required. The plates were then incubated at 37 oC for 3 h for adhesion of the 
conidia to the surface of the wells under static conditions. Subsequently, the 
growth suspension was replaced with pre-sterilised 250 L of RPMI 1640 (pH 
7) medium containing GF:HPMCAS (chloroform solvate) and non solvated 
(prepared from acetone). The concentration of the formulations used in this 
study were equivalent to the known MIC90 of griseofulvin against T. rubrum (8 









laboratory standards institute (CLSI) guidelines M38-A2 for fungal work. 
Biofilm of T. rubrum NCPF 935 was grown with and without the addition of the 
formulation and grown for a period of 96 h at 37 oC prior to carrying out 
subsequent assays.  
The concentration of GF:HPMCAS (solvated and non-solvated) used in this 
study are provided in Table 1 (supplementary material). The total 
concentration (w/v) of GF:HPMCAS used for the in vitro studies was based on 
MIC90 of GF as per published literature. DMSO when diluted in RPMI without 
the formulations did not exhibit any inhibitory effects on T. rubrum NCPF 953. 
 
2.13. Metabolic activity of T. rubrum NCPF 935 by XTT assay 
XTT assay was used based on the method described by Costa-Orlandi et al., 
2014 with a few modifications [16]. The assay was used in this study to 
quantify the metabolic activity of the biofilm with and without the presence of 
the formulations. Stock solutions of XTT (2,3-bis (2-methoxy-4-nitro-5-
sulfophenyl)-5- [carbonyl (phenylamino)]-2H-tetrazolium hydroxide) and 
menadione were prepared, 1 mg/mL in PBS and 1 mM ethanol respectively, 
and stored at 4 oC. T. rubrum NCPF 935 biofilms were grown with and without 
the presence of the formulations that showed the highest biofilm inhibition. 
Samples were analysed at 3, 8, 24, 48, 72 and 96 h. To the samples, 50 L of 
XTT solution was added along with 4 L of menadione into the 96-well plates 
and incubated at 37 oC for 3 h. The resulting formation of formazan salts and 
colorimetric change were measured in a plate reader at 490 nm (FLUOstar 
Optima, BMG labtech, UK). RPMI 1640 medium, free of biofilm was used as a 










2.14. Protease activity of T. rubrum NCPF 935 
Proteolytic activity of T. rubrum NCPF 935 was measured with and without the 
presence of formulations. The method used in this study was based on Al-
Janabi and Al-Hamadani, 2015 with a few modifications [19]. Briefly, T. 
rubrum NCPF 935 was grown in PDB (potato dextrose broth) (Sigma-Aldrich, 
UK) at 37 oC in a rotary shaker at 4 RCF for 7 days. Casein from bovine milk 
(1% w/v) (Sigma-Aldrich, UK) was used to determine the proteolytic activity. 
Briefly, to 500 L of the casein substrate, 500 L of T. rubrum NCPF 935 
filtrate treated with and without the formulations was added along with 100 L 
of 0.5 M tris-HCL (pH 8) in test tubes. The reaction was carried out at 40 oC 
for 30 min and stopped by adding 2 mL of 0.67 M trichloro acetic acid (TCA). 
The test tubes were allowed to rest at room temperature for 1 h. The 
precipitate formed was removed by centrifugation at 5000 rpm for 15 min. The 
absorbance was then measured at 280 nm using a spectrophotometer against 
a blank where TCA was added prior to the incubation period. Unit of 
enzymatic activity was defined as the amount of enzyme that produced 
products by breaking down casein giving an absorbance of 0.1 at 280 nm 
under the experimental conditions. The following formula was used to 
calculate the activity of protease per mg of protein.  












2.15. Confocal laser scanning microscopy of T. rubrum NCPF 935 
biofilm 
Biofilms of T. rubrum NCPF 935 were grown in 6-well tissue culture (Nunc) 
plates in RPMI-1640 medium at 37 oC for a period of 72 h with and without the 
addition of GF:HPMCAS (chloroform solvate) and non solvated (prepared 
from acetone). FUN-1 (Molecular probes, Invitrogen) was prepared according 
to manufactures instructions and was used to stain T. rubrum NCPF 935 
biofilm as mentioned by Costa-Orlandi et al., 2014 with a few modifications 
[16]. Briefly, the biofilm was gently washed using 0.9% (v/v) saline solution 
and treated with 300L of FUN-1 fluorescent stain for 45 min and incubated at 
37oC protected from light. After the incubation period, the excess stain was 
gently washed using HEPES buffer after which, the biofilms were visualised at 
~485 nm excitation/ ~530 nm emission (green) using a Leica TSC SP2 
confocal microscope (Heidelberg, Germany).  
 
2.16. Data analysis 
All experiments were conducted in triplicate unless mentioned otherwise. 
Statistical analysis was conducted using one-way ANOVA (Tukey's multiple 
comparision test). A P value of < 0.05 was considered to be significant. Data 
processing was performed using GraphPad Prism 7 for windows, GraphPad 













3. Results  
3.1. Thermal analysis of GF solid dispersions 
Assessment of drug/polymer interaction was based on solid solubility, which 
was evaluated using melting point depression of corresponding physical 
mixtures (Fig 1).  As can be seen in Fig. 1, GF-HPMCAS showed lowest 
depression of approximately 50 °C.  On the contrary there was minimal 
change in GF melting in silica and MCC dispersions signifying minimum 
impact on the crystallinity of GF.  Due to degradation of PVP, measurement of 
GF melting in GF/PVP was not possible.  
 
The solvated solid dispersions were also evaluated to determine any changes 
in the melting point (Fig 1). Formation of the GF solvate was evident in the 
DSC thermograms where an endothermic peak was clearly visible at 
approximately 97°C (Fig. 1). This peak corresponds to the melting of 
chloroform solvate crystals, which was confirmed via cooling cycle that 
showed disappearance of this endotherm.   The endotherm seen was 
significant with a heat of fusion of approximately 84 J/g.  Once the solvate 
melted, another endothermic event was seen at higher temperature attributed 
to the melt of the GF free crystals (non-solvated).  The melting endotherm 
onset of GF was 218 °C for GF prepared in chloroform (solvated), 220 and 
219 °C for GF prepared in acetone and methanol (non-solvated), respectively.   
The heat of fusion of crystalline GF was 86 J/g and reflected the presence of 
the chloroform solvate because the heat of fusion for GF re-crystalized in 
acetone and methanol was 115 J/g.   This difference in heat of fusion reflects 









chloroform crystals.  These results agreed with previous research on GF 
solvates where the melting of the solid-chloroform solvate occurred at 147 °C 
[20].  The lower melting peak in our results is caused by the mixing with 
different polymers which affected the onset of the endotherm but not the 
extent of solvation. As can be seen in Fig. 1, the chloroform solvate peaks 
were observed in the temperature range 85-135 °C.  Differences in the 
melting onset seen among different excipients reflect variations in molecular 
interactions where HPMCAS dispersions showed lowest onset of solvate 
melting. Variation of the molar ratio of the solvent-GF were found previously to 
affect the onset of the melt as was shown for different solvates [21]. This 
possible variation was avoided via using similar ratio of the solvent throughout 
this study.   
 
 
3.2. Characterization of formed dispersions by XRPD  
The effect of the polymer on solvate formation was studied by analysing the 
crystalline patterns (Fig. 2). The evidence of the solvate form was confirmed 
by the observation of the peaks at 11.3°, 15.3° and 26.5°.  .  It was also clear 
that some of the peaks were less intense in the drug/polymer mixtures. This 
could indicate presence of the partially amorphous form formation because of 
the influence of the polymer. 
 
The formation of the solvate was investigated further and the results can be 
seen in Fig. 2. New peaks were seen in the scan at 2θ of 11.2°, 15.3°, 17.5°, 









the chloroform GF solvate.  These results indicate that the GF chloroform 
solvate was formed.  It was still possible to observe other peaks, which 
indicates that the formed solvate contributed only partially to the crystalline 
structure of GF.   Changes from the chloroform solvate orthorhombic form to 
non-solvated tetragonal (depicted from the crystalline structures) were 
observed when temperature was increased from 30 to 200 °C and the solvate 
disappeared completely at 120 °C.   These results were similar for all drug-
polymer combinations.  The peaks positions, and in particular at 11.2°, were 
changing gradually and started to appear at 80 °C.  
 
 
Fig. 2: (A) X-ray powder diffraction scans of 1:1 (GF : polymer) prepared in 
acetone, chloroform and methanol and (B) X-ray powder diffraction scans of 
1:1 (GF:HPMCAS) chloroform solvate as a function of temperature showing 
polymorphic changes that start to occur ~90 °C.  These changes result from 
the loss of the solvate structure at this temperature range.  
 
3.3. Hydrogen bonding analysis of polymer-GF interactions  
While the formation of GF solvates was reported previously for different 
solvents [22, 23], limited studies were carried out of solvated polymeric 
dispersions. Fig. 3 shows the FTIR spectra obtained from 1:1 GF-polymer 
solid dispersions in acetone, chloroform and methanol.  The very broad peak 
at 1730-1750cm-1 is associated with the carbonyl group stretching of 
HPMCAS. The peaks at 1705cm-1 and 1657cm-1 correspond to the stretching 
of the benzofuran and cyclohexene carbonyl groups in GF [24].  In the 
chloroform solid dispersion these peaks have shifted to 1694cm-1 and 1666 
cm-1 respectively, indicating the presence of hydrogen bonding between 










The peaks at 1615cm-1 and 1585cm-1 are typically associated with the C=C 
stretch of the aromatic ring in griseofulvin. Interestingly, in the spectrum of the 
chloroform solid dispersion the small peak at 1599cm-1 which represents the 
aromatic C=C stretch in griseofulvin disappears. Its absence indicated 
significant polymorphic changes.  The shifts were identical among different 
polymers, which indicated predominant impact of the solvent (chloroform) in 






3.4. Effect of different polymers on the solubility of griseofulvin (GF)  
The saturation solubility of GF solid dispersions prepared in acetone, 
chloroform and methanol are shown in Fig. 4. The solubility of GF chloroform 
solvate was the lowest compared to that prepared from acetone or methanol 
(35, 45 and 70 μg/mL, respectively).  However, as shown in Fig. 4, 
incorporation of the polymers has increased the solubility of the chloroform 
dispersion compared to GF alone.  The extent of this enhancement ranged 
from 31% for GF-MCC to 132.9% for GF-HPMCAS solid dispersions as 
measured after 72 hours.  The solubility patterns in the initial 5 hours were 
largely similar to that of saturation solubility, with HPMCAS being the most 
soluble and MCC being the lowest in this ascending order: MCC < silica < 










The ability of HPMCAS to improve drug dissolution and prevent drug 
recrystallization was also evident.  HPMCAS proved to be the most effective 
polymer to enhance solubility, with an increase up to 150%.  This was 
particularly evident in GF-HPMCAS chloroform solvate, which outperformed 
the GF-HPMCAS in acetone solid dispersion by as much as 73%. 
Improvements in solubility were also evident in all other polymers, with the 
exception of silica, which solubility is almost similar to that in acetone 








3.5. Antifungal activity of solvate dispersions  
Formation of a biofilm is essential in the pathogenicity of T. rubrum to cause 
chronic superficial fungal infections such as onychomycosis (fungal nail 
infections). In vitro growth of T. rubrum NCPF 935 and subsequent antifungal 
assays displayed a significant reduction in the biofilm production (p < 0.0001) 
after the exposure to GF:HPMCAS chloroform solvate and non-solvated 
GF:HPMCAS prepared from acetone when compared to the untreated 
control.. GF chloroform solvate was found to be more effective in antagonising 









acetone as shown in Fig. 5 (a, b, c). As both forms of GF showed significant 
reduction in biofilm compared to the untreated control, this in turn reflects the 
impact of preparing the drug as a solid dispersion and the possible 
antagonistic activity of HPMCAS towards the negating the pathogenicity of T. 
rubrum. The antifungal activity of solvated (chloroform) and non- solvated 
(acetone) GF against T. rubrum NCPF 935 is clearly observed with the XTT 
assay wherein a significant reduction in metabolic activity was observed after 
8h (Fig 5). This decreased metabolic activity was observed for the entire 
duration of the experiment starting 8h at time point. Data obtained from the 
XTT assay correspond to the reduction of the biofilm with the treatment due to 
lowered activity of T. rubrum NCPF 935 and its ability to produce biofilm.   As 
shown in Fig 5, the GF chloroform solvate and non-solvated GF prepared 
from acetone showed a significant reduction in protease activity. This reflects 
reduced keratinolytic activity, which is important to note as one of the primary 
virulence factors of dermatophytes.   
 
 
Formation of hyphae is a prerequisite for fungal attachment to a substratum 
and formation of the biofilm. Assessing the effect of GF formulations on T. 
rubrum NCPF 935 hyphae and biofilm development by Confocal laser 
scanning microscopy showed a change in morphology of T. rubrum NCPF 
935 hyphae (density, thickness) as well as absence of conidia with treatment 
after a period of 72 h. Treatments therefore showed significant antagonism 









fungi. Similarly, absent conidia signify the reduced ability of T. rubrum NCPF 
935 to sporulate, thereby negating the spread of the infection.  
 
The chloroform solvate of GF-HPMCAS was found to have a higher impact on 
inhibiting the biofilm development of T. rubrum NCPF 935. This could be 
clearly seen in Fig 5, as thicker hyphae but not as dense were observed in 
GF-HPMCAS dispersions (non-solvated).  On the contrary, significant 
reduction in the thickness and density as thin hyphae could be seen in the 
GF-HPMCAS dispersions (solvated). Overall, a lack of conidia in T. rubrum 










3.6. Analysis of solid and liquid state interactions using solid and liquid 
state NMR 
Solvated GF-HPMCAS dispersion showed higher antifungal activity when 
compared to non-solvated form.  To fully understand the mechanism of this 
enhancement, it is important to find whether the crucial interactions, which 
were established in the liquid state, are also retained in the solid state. 









problem because its offer direct inside into molecular structure in the solution 
(liquid state NMR) and solid (solid-state NMR) and its able to provide detailed 
information on a very subtle interactions, including hydrogen bonds. 
 
To be able to correctly compare and analyse solution and solid-state NMR 
results, the full assignment of all signals in 13C NMR spectra of GF was 
required (Fig. 6 and Table 1). The assignment of the signals in13C NMR 
spectrum of GF was found to be in good agreement with previously published 
data [25] as presented in Fig. 6A and Table 1. 13C solid-state NMR spectrum 
of pure GF showed the presence of additional signals (195 ppm and new 
signal between 91 and 90 ppm), which could not be attributed to spinning 
sidebands. This strongly suggests the coexistence of different isomers, 
possibly with distinctive patterns of hydrogen bonding in the crystalline 
dispersion as observed before [26].  This is supported by the observation that 
resonances from the carbons C5, C2 which should be particularly sensitive to 
hydrogen bonding are present around 195 ppm and in the region between 95 
and 90 ppm.  
 
The 13C solid-state NMR spectra of GF, HPMCAS and GF and HPMCAS 
dispersions are compared in Fig. 6B. There was no significant difference 
between the spectra of physical mixture of GF and HPMCAS and a sum of the 
separate GF and HPMCAS spectra (Fig. 6B).  This suggests negligible 
interaction in the physical mixture regardless of any conformational 













Fig. 6B (ii-v) compares 13C solid-state NMR spectra of GF:HPMCAS 
dispersions prepared from chloroform, acetone and methanol with the 
spectrum of the physical mixture. For dispersions prepared from methanol, no 
differences were observed in the chemical shifts between the physical mixture 
and methanol dispersion indicating minimum impact of methanol on the 
formation of the dispersion.  On the other hand, the dispersion prepared using 
acetone showed significant broadening of the signals attributed to GF with 
mostly unchanged HPMCAS signals. For example, peaks at 97.9 and 94.5 
ppm have merged into one broad structure at 96 ppm. These changes 
indicate the formation of amorphous GF dispersion, which agreed with the 
XRPD data shown above.   
 
When comparing the chemical shifts in the spectra of the dispersion prepared 
from chloroform, significant changes were observed especially for C14 and 
C21 carbons (Table 1, Fig. 6A). The downfield shift in δC14 (δsolid < δsolution < 
δcomplex) suggests that stronger hydrogen bonding in the chloroform complex 
compared to chloroform solution.  In general, there were significant 
differences in the carbon chemical shift between solution, complex – 
dispersion and crystalline samples. This is consistent with the highly 
constrained crystalline structure, compared with the solution where mobility of 









chemical shifts, suggests that the structure of the chloroform complex-




4. Discussion  
GF was shown before to have weak activity against T. rubrum isolates [27]. 
However, in our work, the metabolic and protease activity of T. rubrum NCPF 
935 with and without the presence of GF:HPMCAS chloroform solvates 
showed significant reduction compared to the untreated control after 24 h 
period.   This was clearly visible in confocal laser scanning microscopy which 
showed disappearance of the hyphae compared to Control and GF:HPMCAS 
(non solvated).  Chloroform extracts were shown before to have low activity 
against T. rubrum fungal strains [28].  Therefore, results shown demonstrate 
novel role for the polymeric dispersion in augmenting the activity of the 
antifungal drug GF.    
 
HPMCAS solvate dispersions were more stable when compared with other 
polymers, which may explain the observed synergistic effect.  As can be seen 
in Figure 7, dynamic vapour sorption data showed recrystallization of all 
solvate dispersions when the relative humidity was increased to around 70%.  
The loss in mass was a sign of loss of bound and non-bound water (or 
solvate). No recrystallization (or solvate loss) could be observed in HPMCAS 
solvate dispersions upon sorption and desorption cycles which indicates that 











Hydrogen bonding between the hydrogen in chloroform molecule and the 
carbonyl on GF explains the basis for GF chloroform solvate formation, which 
was clearly visible in the FTIR analysis.   This ability to form hydrogen 
bonding is based on the fact that chloroform acts as Lewis acid with the 
potential to form hydrogen bonds with corresponding bases [29, 30].  When 
different polymers were incorporated, the GF solvate was affected.  For 
example, HPMCAS resulted in the disruption of the solvate crystalline lattice 
likely by formed hydrogen bonding as was shown in 13C solid-state NMR 
spectra. Polymorphic changes were confirmed using XRPD where data 
showed despite that part of GF existed as amorphous; the main polymorphic 
structure was the solvate form.  This was clear in Fig 2 where the increase in 
the temperature to 80°C was associated with the disappearance of the 
solvate and appearance of form I GF polymorph.  The extensive hydrogen 
bonding for GF-HPMCAS chloroform solvate has been shown to enhance the 
solubility of GF.  This trend has also been seen for PVP where improvement 
in solubility could also be observed when compared with the solubility of silica 
and MCC dispersions.  
 
 
This suggests that solvates, which were formed in the liquid state, maintained 
their structures in the solid state.  Such behaviour was reported previously 
where lithium solvates were shown to remain stable in solutions of aprotic 
solvents and affected the properties of those solutions [31].  Similarly, it is 









structure and assisted in enhancing solubility via Cl…Cl interactions together 
with the formed hydrogen bonds with GF and HPMCAS.   This could be 
possible reason for the increased antifungal activity of GF-HPMCAS solvate, 
which was 2-5 times stronger when compared with the activity of GF alone.  
Synergistic effect was also caused by prevention of recrystallization and 
solvate expulsion as evident in Fig. 7, which could explain the disruptive effect 




5. Conclusions  
The results of this work showed that the griseofulvin solvate had a 
significantly higher antifungal activity against dermatophytes compared to 
non-solvated form.  This synergistic effect was achieved by carefully planned 
crystal engineering in which the drug properties were changed via dispersing 
it into a matrix.  Solvated crystals of griseofulvin embedded within the 
HPMCAS matrix showed higher dissolution properties with evidence of 
hydrogen bonding.  The most significant impact of these distinctive molecular 
interactions present in the solvate form was observed in the antimicrobial 
assay where the fungal threads dramatically diminished when treated with the 
chloroform solvate form of griseofulvin.   Solution and solid-state NMR 
experiments demonstrated that solvent molecules play important role in the 
formation of very specific microstructure of the GF solid dispersions. In 
particular, the interaction between GF and chloroform were found to be similar 









of the solvate. Our findings further signify the role of precise crystal 
engineering in preparing highly potent versions of griseofulvin.  
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Fig. 1: Thermograms of GF mixtures with polymers (A) showing the melting 
point of GF in physical mixtures with the polymers, and (B) showing 
thermograms of solid dispersions prepared in chloroform, methanol, acetone 
using a weight ratio of 1:1. The chloroform solvate peaks can be seen in the 










Fig. 2: (A) X-ray powder diffraction scans of 1:1 (GF : polymer) prepared in 
acetone, chloroform and methanol and (B) X-ray powder diffraction scans of 
1:1 (GF:HPMCAS) chloroform solvate as a function of temperature showing 
polymorphic changes that start to occur ~90 °C.  These changes result from 
the loss of the solvate structure at this temperature range.  
 
Fig. 3: FTIR scans of 1:1 (GF : polymer) prepared in acetone, chloroform and 
methanol showing significant changes in the chloroform solvates as reflected 










Fig. 4: saturated solubility measurements showing solubility of pure GF 
crystallized from different solvents and GF : polymer (1:1) prepared using 
different solvents.  Measurements were performed in a phosphate buffer 










Fig. 5: (A) Quantification of biofilm formed by T. rubrum NCPF 935 by 
safranin staining. Compared to the control, the use solvated and non solvated 
GF:HPMCAS dispersions showed a significant reduction in biofilm content (p< 
0.0001), (B) Metabolic activity of T. rubrum NCPF 935 with and without the 
presence of formulations GF:HPMCAS (chloroform solvate) and GF:HPMCAS 
non solvated (prepared from acetone) showed a significant reduction 
compared to the untreated control after 24 h period 96 h (n=3), (C) 
Quantification of protease activity by T. rubrum NCPF 935 showing significant 
reduction (p< 0.0001) in protease activity (n=5) and (D) confocal laser 
scanning microscopy images of T. rubrum NCPF 935 with and without 
treatment after 72 h (magnification at 630x). i) Control T. rubrum growth 
shows conidia (white arrows) and dense hyphae. ii) Treatment with 
GF:HPMCAS non solvated (prepared from acetone) showed thicker hyphae 
but not as dense. iii) Treatment with GF:HPMCAS (chloroform solvate) 
showed thin hyphae compared to Control and GF:HPMCAS non solvated 










Fig. 6: (A) Molecular structure of GF and the assignment of the carbon atoms 
to the resonances recorded in (ii) solid-state and (i) solution 13C NMR spectra. 
(B) Comparison of 13C solid-state NMR spectra of (i) GF and HPMCAS, (ii) 
physical mixture of GF and HPMCAS, and GF:HPMCAS dispersions prepared 










Fig. 7: Dynamic vapur sorption isotherms for GF solid dispersions prepared 





Table 1: A summary of NMR chemical shifts as measured for GF:HPMCAS 
(1:1) using 13C CPMAS and 13C liquid NMR and their assignment to the 
molecular structure of GF (see Fig. 6A for full numbering of carbon atoms). 
Atom 
13C chemical shift / ppm  







physical mixture dispersion Chloroform 
C2 90.7sh or 94.6   90.7 or 93.2  - 90.78 
C3 37.5 37.8 -0.3 36.44 
C4 39.5 41.3 -1.8 40.06 
C5 195.0 195.9 -0.9 197.04 
C6 102.8 104.7 -1.9 104.9 
C7 168.5 170.0 -1.5 170.78 
C8 170.3 171.3 -1 169.55 
C9 97.8 98.9  -1.1 97.30 
C10 164.2 165.8 -1.6 164.61 
C11 91.5  90.7 0.9 89.48 
C12 158.0 159.1 -1.1 157.76 









C14 190.4 193.8 -3.4 192.49 
C15 13.1 14.8 -1.7 14.25 
C18 55.3 56.7 -1.4 56.68 
C21 59.6 57.3 2.3 57.01 
C23 58.6 57.3 1.3 56.39 
*C* 194.4sh 195.0sh - - 
*C* 90.7sh or 94.6   90.7 or 93.2 - - 
sh – shoulder to the peak 
*C* - refers to the additional peaks  
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